Collectively, METTL16 regulates BLCA growth and chemotherapy response in an m6A-dependent manner through the HIF-2α–METTL16–PMEPA1–autophagy axis, providing novel mechanistic insights and potential therapeutic strategies for bladder cancer (47). The gene discussed is METTL16; the disease is urinary bladder carcinoma.